A process optimization for bio-catalytic production of substituted catechols (3-nitrocatechol and 3-methylcatechol

Area of Science:

• Biotechnology
• Industrial Microbiology
• Biocatalysis

Background:

• Substituted catechols are vital industrial precursors.
• Current chemical synthesis methods are costly and inefficient for large-scale production.
• Biocatalytic processes offer a selective and industrially viable alternative.

Purpose of the Study:

• To optimize the biocatalytic production of 3-substituted catechols, specifically 3-nitrocatechol (3-NC) and 3-methylcatechol (3-MC), at a pilot scale.
• To identify and utilize microbial strains capable of accumulating these target compounds.
• To refine process parameters for maximizing yield and efficiency.

Main Methods:

• Screening of microbial strains, including Pseudomonas putida (F1) and a recombinant Escherichia coli expression clone (pDTG602).
• Optimization of laboratory-scale parameters: nutrients, pH, temperature, substrate concentration, aeration, inoculum size, culture volume, and toxicity.
• Pilot-scale fermentation in a 2.5-liter bioreactor, focusing on downstream extraction and biotransformation efficiency.

Main Results:

• Identified P. putida (F1) for 3-NC accumulation and E. coli (pDTG602) for 3-MC accumulation.
• Achieved significant increases in product accumulation rates (90-95%) at pilot scale.
• Obtained high yields of 10 mM 3-NC and 12 mM 3-MC through optimized biocatalytic processes.

Conclusions:

• Biocatalytic production of 3-NC and 3-MC is highly dependent on critical process parameters for maximizing pilot-scale yields.
• The optimized process utilizing P. putida (F1) and recombinant E. coli (pDTG602) demonstrates significant potential for industrial-scale application.
• This bio-based approach offers a sustainable and efficient route for producing valuable substituted catechols.